Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase

被引:116
作者
Lepley, RA
Muskardin, DT
Fitzpatrick, FA
机构
[1] Department of Pharmacology C236, University of Colorado, Health Science Center, Denver
[2] Dept. of Pharmacology C236, University of Colorado, Health Science Center, Denver, CO 80262
关键词
D O I
10.1074/jbc.271.11.6179
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tyrosine kinase activity, a determinant of Src homology domain interactions, has a prominent effect on cellular localization and catalysis by 5-lipoxygenase. Six separate inhibitors of tyrosine kinase each inhibited 5(S)-hydroxyeicosatetraenoic acid formation by HL-60 cells stimulated with calcium ionophore, in the presence or absence of exogenous arachidonic acid substrate, indicating that they modulated cellular 5-lipoxygenase activity. The tyrosine kinase inhibitors also blocked the translocation of 5-lipoxygenase from cytosol to membranes during cellular activation, consistent with their effects on its catalytic activity. These results fit a model which postulates that Src homology domain interactions are a molecular determinant of the processes which coordinate the subcellular localization and functions of 5-lipoxygenase. In addition, we demonstrate that activated leukocytes contain two molecularly distinct forms of 5-lipoxygenase: a phosphorylated form and a nonphosphorylated form. In activated HL-60 cells the pool of phosphorylated 5-lipoxygenase accumulates in the nuclear fraction, not with the membrane or cytosolic fractions. The amount of phosphorylated 5-lipoxygenase is a small fraction of the total. Overall, equilibrium reactions involving the nuclear localizing sequence, the proline-rich SH3 binding motif, and the phosphorylation state of 5-lipoxygenase may each influence its partnership with other cellular proteins and any novel functions derived from such partnerships.
引用
收藏
页码:6179 / 6184
页数:6
相关论文
共 46 条
  • [1] Akiyama T., 1991, METHOD ENZYMOL, V201, P362
  • [2] ALVAREZ E, 1991, J BIOL CHEM, V266, P15277
  • [3] BROCK TG, 1994, J BIOL CHEM, V269, P22059
  • [4] CHARLESON S, 1992, MOL PHARMACOL, V41, P873
  • [5] CDNA CLONING, EXPRESSION, MUTAGENESIS, INTRACELLULAR-LOCALIZATION, AND GENE CHROMOSOMAL ASSIGNMENT OF MOUSE 5-LIPOXYGENASE
    CHEN, XS
    NAUMANN, TA
    KURRE, U
    JENKINS, NA
    COPELAND, NG
    FUNK, CD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) : 17993 - 17999
  • [6] COFFEY M, 1992, J BIOL CHEM, V267, P570
  • [7] DENIS D, 1991, J BIOL CHEM, V266, P5072
  • [8] REQUIREMENT OF A 5-LIPOXYGENASE-ACTIVATING PROTEIN FOR LEUKOTRIENE SYNTHESIS
    DIXON, RAF
    DIEHL, RE
    OPAS, E
    RANDS, E
    VICKERS, PJ
    EVANS, JF
    GILLARD, JW
    MILLER, DK
    [J]. NATURE, 1990, 343 (6255) : 282 - 284
  • [9] CYTOPLASMIC PHOSPHOLIPASE-A(2) TRANSLOCATES TO MEMBRANE-FRACTION IN HUMAN NEUTROPHILS ACTIVATED BY STIMULI THAT PHOSPHORYLATE MITOGEN-ACTIVATED PROTEIN-KINASE
    DURSTIN, M
    DURSTIN, S
    MOLSKI, TFP
    BECKER, EL
    SHAAFI, RI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) : 3142 - 3146
  • [10] CRITERIA FOR THE IDENTIFICATION OF NONREDOX INHIBITORS OF 5-LIPOXYGENASE
    FALGUEYRET, JP
    HUTCHINSON, JH
    RIENDEAU, D
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (04) : 978 - 981